Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the number warrants outstanding as of September 30, 2020 and December 31, 2019:


	Number of Shares				Weighted Average Exercise Price (C$)		Weighted Average Contractual Life		Number of Shares		Weighted Average Exercise Price (USD)		Weighted Average Contractual Life
	Liability Classified								Equity Classified
Balance as at December 31, 2019		2,406,811		C$		18.59		4.86		-	$	-		-
Additional Modification Warrants		84,924				14.03		5.00		-		-		-
Dispensary Mortgage Warrants		-				-		-		35,000		9.10		5.00
Warrants Exercised		(5,941	)			12.42		5.00		-		-		-

Balance as at September 30, 2020		2,485,794		C$		18.45		4.87		35,000	$	9.10		5.00

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date

(s

ee Note 13 - Fair Value Measurements for additional details

)

:


Significant Assumptions	September 30, 2020		December 31, 2019
Volatility		85.36 % - 89.50 %		117.43 % - 123.64 %
Remaining Term		2.03 - 4.64 years		2.78 - 4.86 years
Risk Free Rate		0.25 % - 0.34 %		1.68% - 1.69 %

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the equity classified warrants as of each reporting date:


Significant Assumptions	September 30, 2020			December 31, 2019
Volatility		80	%		—
Remaining Term		5 years			—
Risk Free Rate		0.37	%		—

Class of Warrant or Right [Line Items]